SecBot SecBot
SECBOTREPLAY Home › Report › IRTC

IRTC · iRhythm (IRTC) presented new real-world data at HRS 2026 showing that…

iRhythm · PRESS-RELEASE filed Apr 27, 2026 at 08:05 ET

At the news

BULLISHIMPACT 7/10

PRESS-RELEASE filed Apr 27, 2026 at 08:05 ET

iRhythm (IRTC) presented new real-world data at HRS 2026 showing that 26% of atrial fibrillation (AF) recurrences after ablation and 60% of clinically significant arrhythmias in pregnant patients are missed with standard 24–48-hour Holter monitoring, reinforcing the clinical advantage of its 14-day Zio ambulatory ECG monitoring. The findings support broader adoption of extended monitoring to improve diagnosis, anticoagulation decisions, and maternal care.

  • 26% of AF recurrences after ablation were detected beyond 48 hours, meaning short-term monitoring would misclassify up to 1 in 4 patients as false negatives.
  • 60% of clinically significant arrhythmias in pregnant patients were first detected after 48 hours, with 13.6% having such events.
  • Study included 11,051 post-ablation patients and 486 pregnant women monitored via Zio devices.
  • 99.2% median analyzable time in pregnancy study confirms high data quality with Zio monitoring.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access